Valeant Pharmaceuticals chief Michael Pearson is a billionaire no more. In early August, when the Canadian drug company's stock was peaking, his 10.1 million shares and other equity awards were worth about $2.64 billion. After a forced sale of 1.3 million shares to pay off a loan Thursday, the value of Pearson's Valeant holdings is...
Valeant Pharmaceuticals chief Michael Pearson is a billionaire no more. In early August, when the Canadian drug company's stock was peaking, his 10.1 million shares and other equity awards were worth about $2.64 billion. After a forced sale of 1.3 million shares to pay off a loan Thursday, the value of Pearson's Valeant holdings is...
Share this Article
Comment on this Article
Recommended
Please to comment